Cardiology
The Novo Nordisk Foundation is going global on cardiometabolic disease.
One of the world’s largest foundations is directing more funding beyond Denmark and making obesity, diabetes and cardiovascular disease a central international priority. The investment could fill a dangerous gap in global health. It also raises a harder question: when public systems underfund chronic disease, how much influence should private philanthropy have over what gets…
Treating hypertension in pregnancy is possible. Making it routine care is the policy challenge
Ultra-processed food may leave a metabolic fingerprint in the blood.
New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly
Moldova Is Taking Vaccines To Roma Communities. Respect Is Part Of Delivery.
Merck KGaA’s Saturnus Bio bet signals a shift to genotype-driven cardiology, and a looming readiness gap for health systems
Same country, different risks: why Iranian women’s heart disease profiles expose a blind spot in prevention policy
Indigenous cardiovascular inequity is not a data gap. It is a policy failure
Cardiology has too many dashboards. The danger is forgetting the patient
GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.